2017 ACI Transitional Measure: Syndromic Surveillance Reporting

MIPS >> Advancing Care Information >> Syndromic Surveillance Reporting

Note: Practice Fusion is committed to supporting our customers participating in MIPS in 2017. As a MIPS participant in 2017, you can use the Practice Fusion EHR and other tools to help you monitor your MIPS performance during your chosen 2017 reporting period. We are also continuing to actively work to further enhance our product functionality for MIPS and we will be giving further updates as they become available.

Under the Merit-based Incentive Payment System (MIPS) pathway of the MACRA Quality Payment Program, the Advancing Care Information (ACI) category replaces the Medicare EHR Incentive Program (Meaningful Use). ACI is one of the three performance categories that will be considered and weighted for scoring an eligible clinician’s performance under MIPS (four categories will be included starting in 2018). This bonus score measure can contribute an additional 5% to a clinician’s total ACI score, but the completion of this measure is not required in order to earn the full 100% for the total ACI score. For more information on ACI scoring methodology, please click here.

Reporting Requirements

• YES/NO: To meet this measure, MIPS eligible clinicians must attest YES to being in active engagement with a public health agency to submit syndromic surveillance data.

Locate your local public health agency and initiate contact with them to confirm whether they are able to accept syndromic surveillance data in HL7 2.5.1 format.

Additional Measure Information
CMS has indicated that active engagement may be demonstrated in one of the following ways:

1. Completed Registration to Submit Data : The MIPS eligible clinician registered to submit data with the PHA or, where applicable, the CDR to which the information is being submitted; registration was completed within 60 days after the start of the MIPS performance period; and the MIPS eligible clinician is awaiting an invitation from the PHA or CDR to begin testing and validation. This option allows MIPS eligible clinicians to meet the measure when the PHA or the CDR has limited resources to initiate the testing and validation process. MIPS eligible clinicians who have registered in previous years do not need to submit an additional registration to meet this requirement for each MIPS performance period.
2. Testing and Validation : The MIPS eligible clinician is in the process of testing and validation of the electronic submission of data. MIPS eligible clinicians must respond to requests from the PHA or, where applicable, the CDR within 30 days; failure to respond twice within a MIPS performance period would result in that MIPS eligible clinician not meeting the measure.
3. Production : The MIPS eligible clinician has completed testing and validation of the electronic submission and is electronically submitting production data to the PHA or CDR.

More information

• Review the CMS measure specifications for more information about the requirements for this measure.
• For more information on the Merit-based Incentive Payment System (MIPS) program, you can visit Practice Fusion’s Quality Payment Program Center.
• CMS also provides further resources about the Quality Payment Program here.